AudranM, GareauR, MateckiS, DurandF, ChenardC, SicartMT, MarionB, BressolleF. 1999. Effects of erythropoietin administration in training athletes and possible indirect detection in doping control. Med Sci Sports Exerc, 31:639–645.
2.
BirkelandKI, Stray-GundersenJ, HemmersbachP, HallenJ, HaugE, BahrR. 2000. Effect of rhEPO administration on serum levels of sTfR and cycling performance. Med Sci Sports Exerc, 32:1238–1243.
3.
BogaardHJ, HopkinsSR, YamayaY, NiizekiK, ZieglerMG, WagnerPD. 2002. Role of the autonomic nervous system in the reduced maximal cardiac output at altitude. J Appl Physiol, 93:271–279.
4.
BoushelR, CalbetJA, RadegranG, SondergaardH, WagnerPD, SaltinB. 2001. Parasympathetic neural activity accounts for the lowering of exercise heart rate at high altitude. Circulation, 104:1785–1791.
5.
CalbetJA, BoushelR, RadegranG, SondergaardH, WagnerPD, SaltinB. 2003a. Determinants of maximal oxygen uptake in severe acute hypoxia. Am J Physiol Regul Integr Comp Physiol, 284:R291–303.
6.
CalbetJA, BoushelR, RadegranG, SondergaardH, WagnerPD, SaltinB. 2003b. Why is VO2 max after altitude acclimatization still reduced despite normalization of arterial O2 content?Am J Physiol Regul Integr Comp Physiol, 284:R304–316.
7.
CalbetJA, RadegranG, BoushelR, SaltinB. 2009. On the mechanisms that limit oxygen uptake during exercise in acute and chronic hypoxia: role of muscle mass. J Physiol, 587:477–490.
8.
CalbetJA, RadegranG, BoushelR, SondergaardH, SaltinB, WagnerPD. 2002. Effect of blood haemoglobin concentration on V(O2max) and cardiovascular function in lowlanders acclimatised to 5260 m. J Physiol, 545:715–728.
9.
CerretelliP. 1976. Limiting factors to oxygen transport on Mount Everest. J Appl Physiol, 40:658–667.
10.
DillDB, AdamsWC. 1971. Maximal oxygen uptake at sea level and at 3,090 m altitude in high school champion runners. J Appl Physiol, 30:854–859.
11.
DillDB, MyhreLG, BrownDK, BurrusK, GehlsenG. 1967. Work capacity in chronic exposures to altitude. J Appl Physiol, 23:555–560.
12.
EkblomB, BerglundB. 1991. Effect of erythropoietin administration on maximal aerobic power. Scand J Med Sci Sports, 1:88–93.
13.
EldridgeMW, PodolskyA, RichardsonRS, JohnsonDH, KnightDR, JohnsonEC, HopkinsSR, MichimataH, GrassiB, FeinerJet al.1996. Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema. J Appl Physiol, 81:911–921.
FaoroV, LamotteM, DeboeckG, PavelescuA, HuezS, GuenardH, MartinotJB, NaeijeR. 2007. Effects of sildenafil on exercise capacity in hypoxic normal subjects. High Alt Med Biol, 8:155–163.
16.
FischlerM, MaggioriniM, DorschnerL, DebrunnerJ, BernheimA, KienckeS, MairbaurlH, BlochKE, NaeijeR, Brunner-La RoccaHP. 2009. Dexamethasone but not tadalafil improves exercise capacity in adults prone to high-altitude pulmonary edema. Am J Respir Crit Care Med, 180:346–352.
17.
FulcoCS, RockPB, CymermanA. 1998. Maximal and submaximal exercise performance at altitude. Aviat Space Environ Med, 69:793–801.
18.
GeY, BagnallA, StricklettPK, StraitK, WebbDJ, KotelevtsevY, KohanDE. 2006. Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol, 291:F1274–1280.
19.
GhofraniHA, ReichenbergerF, KohstallMG, MrosekEH, SeegerT, OlschewskiH, SeegerW, GrimmingerF. 2004. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: A randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med, 141:169–177.
20.
GroepenhoffH, van der PlasMN, BelokaS, VillafuerteF, MacarlupuJL, OverbeekMJ, NaeijeR. 2011. Exercise pathophysiology in patients with chronic mountain sickness [abstract]Am J Respir Crit Care Med, 183:A5750.
HsuAR, BarnholtKE, GrundmannNK, LinJH, McCallumSW, FriedlanderAL. 2006. Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia. J Appl Physiol, 100:2031–2040.
23.
KolliasJ, BuskirkER, AkersRF, ProkopEK, BakerPT, Picon-ReateguiE. 1968. Work capacity of long-time residents and newcomers to altitude. J Appl Physiol, 24:792–799.
24.
KresslerJ, StoutenbergM, RoosBA, FriedlanderAL, PerryAC, SignorileJF, JacobsKA. 2011. Sildenafil does not improve steady state cardiovascular hemodynamics, peak power, or 15-km time trial cycling performance at simulated moderate or high altitudes in men and women. Eur J Appl Physiol., 111:3031–3040.
Leon-VelardeF, VillafuerteFC, RichaletJP. 2010. Chronic mountain sickness and the heart. Prog Cardiovasc Dis, 52:540–549.
27.
LundbyC, BoushelR, RobachP, MollerK, SaltinB, CalbetJA. 2008. During hypoxic exercise some vasoconstriction is needed to match O2 delivery with O2 demand at the microcirculatory level. J Physiol, 586:123–130.
28.
LundbyC, CalbetJA, van HallG, SaltinB, SanderM. 2004. Pulmonary gas exchange at maximal exercise in Danish lowlanders during 8 wk of acclimatization to 4,100 m and in high-altitude Aymara natives. Am J Physiol Regul Integr Comp Physiol, 287:R1202–1208.
29.
LundbyC, DamsgaardR. 2006. Exercise performance in hypoxia after novel erythropoiesis stimulating protein treatment. Scand J Med Sci Sports, 16:35–40.
30.
LundbyC, SanderM, van HallG, SaltinB, CalbetJA. 2006. Maximal exercise and muscle oxygen extraction in acclimatizing lowlanders and high altitude natives. J Physiol, 573:535–547.
31.
MaignanM, Rivera-ChM, PrivatC, Leon-VelardeF, RichaletJP, PhamI. 2009. Pulmonary pressure and cardiac function in chronic mountain sickness patients. Chest, 135:499–504.
32.
MooreLG, CymermanA, HuangSY, McCulloughRE, McCulloughRG, RockPB, YoungA, YoungPM, BloedowD, WeilJVet al.1986. Propranolol does not impair exercise oxygen uptake in normal men at high altitude. J Appl Physiol, 61:1935–1941.
33.
NaeijeR. 2010. Physiological adaptation of the cardiovascular system to high altitude. Prog Cardiovasc Dis, 52:456–466.
OlfertIM, LoeckingerA, TremlB, FaulhaberM, FlatzM, BurtscherM, TruebsbachS, KleinsasserA. 2011. Sildenafil and bosentan improve arterial oxygenation during acute hypoxic exercise: A controlled laboratory trial. Wilderness Environ Med, 22:211–221.
36.
PenalozaD, Arias-StellaJ. 2007. The heart and pulmonary circulation at high altitudes: Healthy highlanders and chronic mountain sickness. Circulation, 115:1132–1146.
37.
PiiperJ, ScheidP. 1981. Model for capillary-alveolar equilibration with special reference to O2 uptake in hypoxia. Respir Physiol, 46:193–208.
38.
PughLGCE. 1964. Cardiac output in muscular exercise at 5,800 m (19,000 ft)J Appl Physiol, 19:441–447.
39.
PughLGCE, GillMB, LahiriS, MilledgeJS, WardMP, WestJB. 1964. Muscular exercise at great altitudes. J Appl Physiol, 19:431–440.
ReevesJT, GrovesBM, SuttonJR, WagnerPD, CymermanA, MalconianMK, RockPB, YoungPM, HoustonCS. 1987. Operation Everest II: Preservation of cardiac function at extreme altitude. J Appl Physiol, 63:531–539.
42.
ReevesJT, Leon-VelardeF. 2004. Chronic mountain sickness: Recent studies of the relationship between hemoglobin concentration and oxygen transport. High Alt Med Biol, 5:147–155.
43.
RicartA, MaristanyJ, FortN, LealC, PagesT, ViscorG. 2005. Effects of sildenafil on the human response to acute hypoxia and exercise. High Alt Med Biol, 6:43–49.
44.
RichaletJP, GratadourP, RobachP, PhamI, DechauxM, Joncquiert-LatarjetA, MollardP, BrugniauxJ, CornoloJ. 2005. Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am J Respir Crit Care Med, 171:275–281.
45.
RobachP, CalbetJA, ThomsenJJ, BoushelR, MollardP, RasmussenP, LundbyC. 2008. The ergogenic effect of recombinant human erythropoietin on VO2max depends on the severity of arterial hypoxemia. PLoS One, 3:e2996.
46.
RubinLJ, NaeijeR. 2004. Sildenafil for enhanced performance at high altitude?Ann Intern Med, 141:233–235.
47.
RussellG, GoreCJ, AshendenMJ, ParisottoR, HahnAG. 2002. Effects of prolonged low doses of recombinant human erythropoietin during submaximal and maximal exercise. Eur J Appl Physiol, 86:442–449.
48.
SaltinB, GroverRF, BlomqvistCG, HartleyLH, JohnsonRLJr.1968. Maximal oxygen uptake and cardiac output after 2 weeks at 4,300 m. J Appl Physiol, 25:400–409.
49.
SarnquistFH, SchoeneRB, HackettPH, TownesBD. 1986. Hemodilution of polycythemic mountaineers: Effects on exercise and mental function. Aviat Space Environ Med, 57:313–317.
50.
SchaffartzikW, BartonED, PooleDC, TsukimotoK, HoganMC, BeboutDE, WagnerPD. 1993. Effect of reduced hemoglobin concentration on leg oxygen uptake during maximal exercise in humans. J Appl Physiol, 75:491–498; discussion 489–490.
51.
SeheultRD, RuhK, FosterGP, AnholmJD. 2009. Prophylactic bosentan does not improve exercise capacity or lower pulmonary artery systolic pressure at high altitude. Respir Physiol Neurobiol, 165:123–130.
52.
ShivaS, HuangZ, GrubinaR, SunJ, RingwoodLA, MacArthurPH, XuX, MurphyE, Darley-UsmarVM, GladwinMT. 2007. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res, 100:654–661.
53.
SiebenmannC, BlochKE, LundbyC, Nussbamer-OchsnerY, SchoebM, MaggioriniM. 2011. Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m. High Alt Med Biol, 12:169–177.
54.
SteinackerJM, TobiasP, MenoldE, ReissneckerS, HohenhausE, LiuY, LehmannM, BartschP, SwensonER. 1998. Lung diffusing capacity and exercise in subjects with previous high altitude pulmonary oedema. Eur Respir J, 11:643–650.
SuttonJR, ReevesJT, WagnerPD, GrovesBM, CymermanA, MalconianMK, RockPB, YoungPM, WalterSD, HoustonCS. 1988. Operation Everest II: Oxygen transport during exercise at extreme simulated altitude. J Appl Physiol, 64:1309–1321.
57.
TaylorCT, MoncadaS. 2010. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol, 30:643–647.
58.
TuftsDA, HaasJD, BeardJL, SpielvogelH. 1985. Distribution of hemoglobin and functional consequences of anemia in adult males at high altitude. Am J Clin Nutr, 42:1–11.
59.
WagnerPD. 1996. A theoretical analysis of factors determining VO2max at sea level and altitude. Respir Physiol, 106:329–343.
60.
WagnerPD. 2000a. New ideas on limitations to VO2 max. Exerc Sport Sci Rev, 28:10–14.
61.
WagnerPD. 2000b. Reduced maximal cardiac output at altitude. Mechanisms and significance. Respir Physiol, 120:1–11.
62.
WagnerPD. 2010. The physiological basis of reduced VO2max in Operation Everest II. High Alt Med Biol, 11:209–215.
63.
WagnerPD, AraozM, BoushelR, CalbetJA, JessenB, RadegranG, SpielvogelH, SondegaardH, WagnerH, SaltinB. 2002. Pulmonary gas exchange and acid-base state at 5,260 m in high-altitude Bolivians and acclimatized lowlanders. J Appl Physiol, 92:1393–1400.
64.
WagnerPD, SuttonJR, ReevesJT, CymermanA, GrovesBM, MalconianMK. 1987. Operation Everest II: Pulmonary gas exchange during a simulated ascent of Mt. Everest. J Appl Physiol, 63:2348–2359.
65.
WinslowRM, MongeCC, BrownEG, KleinNG, SarnquistF, WinslowNJ, McKneallySS. 1985. Effects of hemodilution on O2 transport in high-altitude polycythemia. J Appl Physiol, 59:1495–1502.
66.
YoungAJ, SawkaMN, MuzaSR, BoushelR, LyonsT, RockPB, FreundBJ, WatersR, CymermanA, PandolfKBet al.1996. Effects of erythrocyte infusion on VO2max at high altitude. J Appl Physiol, 81:252–259.
